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Introduction
Thromboxane (Tx)A2, a potent vasoconstrictor agent is thought to be a significant mediator of the respiratory failure noted in a variety of clinical and experimental disorders including those related to ischaemia and reperfusion, endotoxaemia, complement activation, microembolization, aspiration and burns. (Fig. 1) (Fig. 2) . These changes were not quantified but were more pronounced with Tx mimic at 10-4 M compared prevented the Tx mimic induced cytoskeletal changes.
Electron microscopy indicated increased permeability based on wide interendothelial gap formation and the transit of HRP (Fig. 3) . EC (Fig. 4) . The Tx mimic induced gap formation was prevented by pretreatment with the Tx receptor antagonist (Fig. 4) .
Discussion
The chemically stable endoperoxide analogue used in these studies is believed to act as a biological mimic of TxA 2. This is indicated by its ability to constrict smooth muscle and, in higher dosage, to aggregate platelets and increase white blood cell chemotaxis. 1 and promote neutrophil diapedesis through EC monolayers. 15 The Tx mimic has identical actions on WBC-EC interaction when tested in vitro. 15 Further, infusion of the Tx mimic in swine led to neutrophil sequestration in the lungs. 28 Activation of these sequestered neutrophils may lead to increased permeability. Although neutrophils may enhance Tx induced permeability they are not necessary for its expression. In other studies oedema has been reported in isolated lungs, free of white blood cells, challenged with nicotine 29 3 or lower torso ischaemia with reperfusion; 33 and in rat lungs challenged with inhaled nicotine. 29 In summary, these data suggest that thromboxane A). directly moderates microvascular permeability in vitro.
